Viewing Study NCT02900560


Ignite Creation Date: 2025-12-25 @ 2:01 AM
Ignite Modification Date: 2026-02-27 @ 4:06 PM
Study NCT ID: NCT02900560
Status: TERMINATED
Last Update Posted: 2022-06-10
First Post: 2016-09-01
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study of Pembrolizumab With or Without CC-486 in Patients With Platinum-resistant Ovarian Cancer
Sponsor:
Organization: